Citations (77)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (8)
Khalid Halahleh, Abeer Yaseen, Isra Muradi, Akram Al-Ibraheem, Iyad Sultan & Mohammad Ma’koseh. (2023) Outcome of Primary Mediastinal Large B Cell Lymphoma Treated with RCHOP. Journal of Blood Medicine 14, pages 147-157.
Read now
Read now
Baptiste Le Calvez, Benoit Tessoullin, Loïc Renaud, Carmen Botella-Garcia, Micha Srour, Steven Le Gouill, Gaelle Guillerm, Rémy Gressin, Stéphanie Nguyen Quoc, Sabine Furst, Adrien Chauchet, David Sibon, Philippe Lewalle, Xavier Poiré, Natacha Maillard, Alban Villate, Michael Loschi, Jérôme Paillassa, Yves Beguin, Rémy Dulery, Jean-Jacques Tudesq, Amandine Fayard, Marie C. Béné, Vincent Camus, Patrice Chevallier & Amandine Le Bourgeois. (2022) Outcomes after allogeneic hematopoietic stem cell transplantation for adults with primary mediastinal B cell lymphoma: a SFGM-TC and LYSA study. Acta Oncologica 61:11, pages 1332-1338.
Read now
Read now
Vincent Camus, Camille Bigenwald, Vincent Ribrag, Julien Lazarovici, Fabrice Jardin & Clémentine Sarkozy. (2021) Pembrolizumab in the treatment of refractory primary mediastinal large B-cell lymphoma: safety and efficacy. Expert Review of Anticancer Therapy 21:9, pages 941-956.
Read now
Read now
Xiaoqin Yang, François Laliberté, Guillaume Germain, Monika Raut, Mei Sheng Duh, Shuvayu S. Sen, Dominique Lejeune, Kaushal Desai & Philippe Armand. (2021) Treatment patterns, healthcare resource utilization, and costs of patients diagnosed with primary mediastinal B-cell lymphoma in the United States. Journal of Medical Economics 24:1, pages 469-478.
Read now
Read now
Jitender Takyar, Monika Raut, Rebekah Borse, Arun Balakumaran & Manu Sehgal. (2020) Relapsed/refractory primary mediastinal large B-cell lymphoma: a structured review of epidemiology, treatment guidelines and real-world treatment practices. Expert Review of Hematology 13:3, pages 275-287.
Read now
Read now
Semira Sheikh & John Kuruvilla. (2019) Pembrolizumab for the treatment of diffuse large B-cell lymphoma. Expert Opinion on Biological Therapy 19:11, pages 1119-1126.
Read now
Read now
Maurizio Martelli, Alice Di Rocco, Eleonora Russo, Salvatore Perrone & Robin Foà. (2015) Primary mediastinal lymphoma: diagnosis and treatment options. Expert Review of Hematology 8:2, pages 173-186.
Read now
Read now
Xavier Poiré & Koen van Besien. (2009) Autologous transplant for primary mediastinal B-cell lymphoma. Expert Review of Hematology 2:1, pages 31-36.
Read now
Read now
Articles from other publishers (69)
Charbel Soueidy & Hampig Raphael Kourie. (2023) Updates in the Management of Primary Mediastinal B Cell Lymphoma. Clinical Lymphoma Myeloma and Leukemia 23:12, pages 866-873.
Crossref
Crossref
Pier Luigi Zinzani, Armando Santoro, Giuseppe Gritti, Pauline Brice, Paul M. Barr, John Kuruvilla, David Cunningham, Justin Kline, Nathalie A. Johnson, Neha Mehta-Shah, Julie Lisano, Rachael Wen, Alev Akyol & Alison J. Moskowitz. (2023) Nivolumab combined with brentuximab vedotin for R/R primary mediastinal large B-cell lymphoma: a 3-year follow-up. Blood Advances 7:18, pages 5272-5280.
Crossref
Crossref
Yuankai Shi, Jie Cui, Hui Zhou, Xiaohong Zhang, Liqun Zou, Junning Cao, Yuhuan Gao, Chuan Jin, Xiaoling Li, Hui Liu, Zhigang Peng, Liping Xie, Huilai Zhang, Weihua Zhang, Hongyu Zhang, Liye Zhong, Fang Zhou, Genny Guo & Wenduo He. (2023) Efficacy and safety of geptanolimab (GB226) for relapsed/refractory primary mediastinal large B-cell lymphoma: an open-label phase II study (Gxplore-003). Cancer Immunology, Immunotherapy 72:9, pages 2991-3002.
Crossref
Crossref
Su Li, Bhupinder Sharma, Siraj Yusuf, Vasiliki Michalarea, Mary Gleeson, Laura Hickmott, Andrew Wotherspoon, Ayoma D. Attygalle, Katherine Vroobel, Simon O'Connor, Yong Du, Andrea Kuhnl, Sunil Iyengar, Dima El-Sharkawi, Ian Chau & David Cunningham. (2023) Outcomes of patients treated with RCHOP with a PET adapted approach for consolidative radiotherapy: a retrospective single centre study at the Royal Marsden hospital. Clinical Lymphoma Myeloma and Leukemia.
Crossref
Crossref
Chiara Masucci, Sara Pepe, Ursula La Rocca, Veronica Zullino, Maria Stefania De Propris, Walter Barberi, Anna Paola Iori, Sabina Martelli, Franco Ruberto, Maurizio Martelli & Alice Di Rocco. (2023) Case Report: Severe cutaneous adverse event associated with checkpoint inhibition in the setting of CAR T-cell therapy: beyond CRS. Frontiers in Oncology 13.
Crossref
Crossref
Emine Ikbal Atli. 2023. Cancer Epigenetics. Cancer Epigenetics
363
378
.
N. G. Gabeeva, D. A. Koroleva, S. A. Tatarnikova, A. K. Smolianinova, D. S. Badmazhapova, S. Yu. Smirnova, E. E. Nikulina, A. V. Belyaeva, E. G. Gemdzhian, V. A. Lapin, E. R. Moskalets, I. E. Kostina, Y. K. Mangasarova, S. A. Shutov, B. V. Biderman, A. B. Sudarikov, T. N. Obukhova, A. M. Kovrigina, G. M. Galstyan & E. E. Zvonkov. (2022) Interim results of the PML-16, PML-19 protocols for primary mediastinal large B-cell lymphoma therapy. Russian journal of hematology and transfusiology 67:3, pages 328-350.
Crossref
Crossref
Joanna Romejko-Jarosinska, Beata Ostrowska, Anna Dabrowska-Iwanicka, Katarzyna Domanska-Czyz, Grzegorz Rymkiewicz, Ewa Paszkiewicz-Kozik, Robert Konecki, Anna Borawska, Agnieszka Druzd-Sitek, Elzbieta Lampka, Wlodzimierz Osiadacz, Michal Osowiecki, Lidia Popławska, Monika Swierkowska, Lukasz Targonski, Joanna Tajer, Grazyna Lapinska, Malwina Smorczewska & Jan Walewski. (2022) High efficacy of intensive immunochemotherapy for primary mediastinal B-cell lymphoma with prolonged follow up. Scientific Reports 12:1.
Crossref
Crossref
Luca Ceriani & Emanuele Zucca. 2022. Nuclear Medicine and Molecular Imaging. Nuclear Medicine and Molecular Imaging
370
386
.
Zahoor Ahmed, Safa Saadat Afridi, Zeryab Shahid, Zarlakhta Zamani, Sana Rehman, Wajeeha Aiman, Maryam Khan, Muhammad Ayaz Mir, Farrukh T. Awan, Faiz Anwer & Raheel Iftikhar. (2021) Primary Mediastinal B-Cell Lymphoma: A 2021 Update on Genetics, Diagnosis, and Novel Therapeutics. Clinical Lymphoma Myeloma and Leukemia 21:11, pages e865-e875.
Crossref
Crossref
Vincent CamusCédric Rossi, Pierre SesquesJustine LequesneDavid Tonnelet, Corinne HaiounEric Durot, Alexandre WillaumeMartin Gauthier, Marie-Pierre Moles-MoreauChloé AntierJulien LazaroviciHélène MonjanelSophie BernardMagalie TardyCaroline Besson, Laure LebrasSylvain ChoquetKatell Le Du, Christophe BonnetSarah BaillyGhandi Damaj, Kamel LaribiHervé MaisonneuveRoch HouotAdrien ChauchetFabrice JardinAlexandra Traverse-Glehen, Pierre Decazes, Stéphanie BeckerAlina Berriolo-Riedinger & Hervé Tilly. (2021) Outcomes after first-line immunochemotherapy for primary mediastinal B-cell lymphoma: a LYSA study. Blood Advances 5:19, pages 3862-3872.
Crossref
Crossref
Bradford S. Hoppe, Ranjana Advani, Sarah A. Milgrom, Richard L. Bakst, Leslie K. Ballas, Bouthaina S. Dabaja, Christopher R. Flowers, Chul S. Ha, David B. Mansur, Monika L. Metzger, Chelsea C. Pinnix, John P. Plastaras, Kenneth B. Roberts, Sonali M. Smith, Stephanie A. Terezakis, Jessica M. Kirwan & Louis S. Constine. (2021) Primary Mediastinal B Cell Lymphoma in the Positron-Emission Tomography Era Executive Summary of the American Radium Society Appropriate Use Criteria. International Journal of Radiation Oncology*Biology*Physics 111:1, pages 36-44.
Crossref
Crossref
Beatrice Casadei, Lisa Argnani, Alice Morigi, Ginevra Lolli, Alessandro Broccoli, Cinzia Pellegrini, Laura Nanni, Vittorio Stefoni, Paolo Elia Coppola, Matteo Carella, Michele Cavo & Pier Luigi Zinzani. (2020) Treatment and outcomes of primary mediastinal B cell lymphoma: a three-decade monocentric experience with 151 patients. Annals of Hematology 100:9, pages 2261-2268.
Crossref
Crossref
Huan Chen, Tao Pan, Yizi He, Ruolan Zeng, Yajun Li, Liming Yi, Hui Zang, Siwei Chen, Qintong Duan, Ling Xiao & Hui Zhou. (2021) Primary Mediastinal B-Cell Lymphoma: Novel Precision Therapies and Future Directions. Frontiers in Oncology 11.
Crossref
Crossref
Marc Armengol, Juliana Carvalho Santos, Miranda Fernández-Serrano, Núria Profitós-Pelejà, Marcelo Lima Ribeiro & Gaël Roué. (2021) Immune-Checkpoint Inhibitors in B-Cell Lymphoma. Cancers 13:2, pages 214.
Crossref
Crossref
John Apostolidis, Ayman Sayyed, Mohammed Darweesh, Panayotis Kaloyannidis & Hani Al Hashmi. (2020) Current Clinical Applications and Future Perspectives of Immune Checkpoint Inhibitors in Non-Hodgkin Lymphoma. Journal of Immunology Research 2020, pages 1-18.
Crossref
Crossref
Irene Papadouli, Jan Mueller-Berghaus, Claire Beuneu, Sahra Ali, Benjamin Hofner, Frank Petavy, Kyriaki Tzogani, Anne Miermont, Koenraad Norga, Olga Kholmanskikh, Tim Leest, Martina Schuessler-Lenz, Tomas Salmonson, Christian Gisselbrecht, Jordi Llinares Garcia & Francesco Pignatti. (2020) EMA Review of Axicabtagene Ciloleucel (Yescarta) for the Treatment of Diffuse Large B-Cell Lymphoma. The Oncologist 25:10, pages 894-902.
Crossref
Crossref
Maria L. Moleti, Anna M. Testi & Robin Foà. (2020) Treatment of relapsed/refractory paediatric aggressive B‐cell non‐Hodgkin lymphoma. British Journal of Haematology 189:5, pages 826-843.
Crossref
Crossref
Jakub Svoboda, Steven M. Bair, Daniel J. Landsburg, Sunita Dwivedy Nasta, Sarah J. Nagle, Stefan K. Barta, Nadia Khan, Joanne Filicko-O'Hara, Sameh Gaballa, Lauren Strelec, Elise Chong, Sheryl Mitnick, Terease S. Waite, Cara King, Hatcher Ballard, Matthew Youngman, James Gerson, John P. Plastaras, Amit Maity, Agata M. Bogusz, Stacy S. Hung, Hisae Nakamura, Reza Nejati, Christian Steidl, Megan Lim, Marco Ruella & Stephen J. Schuster. (2020) Brentuximab vedotin in combination with rituximab, cyclophosphamide, doxorubicin, and prednisone as frontline treatment for patients with CD30-positive B-cell lymphomas. Haematologica 106:6, pages 1705-1713.
Crossref
Crossref
Hui Zhou, Zijun Y. Xu-Monette, Ling Xiao, Paolo Strati, Fredrick B. Hagemeister, Yizi He, Huan Chen, Yajun Li, Ganiraju C. Manyam, Yong Li, Santiago Montes-Moreno, Miguel A. Piris & Ken H. Young. (2020) Prognostic factors, therapeutic approaches, and distinct immunobiologic features in patients with primary mediastinal large B-cell lymphoma on long-term follow-up. Blood Cancer Journal 10:5.
Crossref
Crossref
Christin B. DeStefano, Kieron Dunleavy & Catherine Lai. 2020. Novel Therapeutics for Rare Lymphomas. Novel Therapeutics for Rare Lymphomas
83
100
.
Philippe Armand, Scott Rodig, Vladimir Melnichenko, Catherine Thieblemont, Kamal Bouabdallah, Gayane Tumyan, Muhit Özcan, Sergio Portino, Laura Fogliatto, Maria D. Caballero, Jan Walewski, Zafer Gulbas, Vincent Ribrag, Beth Christian, Guilherme Fleury Perini, Gilles Salles, Jakub Svoboda, Jasmine Zain, Sanjay Patel, Pei-Hsuan Chen, Azra H. Ligon, Jing Ouyang, Donna Neuberg, Robert Redd, Arkendu Chatterjee, Arun Balakumaran, Robert Orlowski, Margaret Shipp & Pier Luigi Zinzani. (2019) Pembrolizumab in Relapsed or Refractory Primary Mediastinal Large B-Cell Lymphoma. Journal of Clinical Oncology 37:34, pages 3291-3299.
Crossref
Crossref
Timothy S. Fenske. (2019) Comment: Is There a Role for Allogenic Hematopoietic Cell Transplantation in Primary Mediastinal Large B Cell Lymphoma?. Biology of Blood and Marrow Transplantation 25:12, pages e354-e355.
Crossref
Crossref
Pier Luigi Zinzani, Armando Santoro, Giuseppe Gritti, Pauline Brice, Paul M. Barr, John Kuruvilla, David Cunningham, Justin Kline, Nathalie A. Johnson, Neha Mehta-Shah, Thomas Manley, Stephen Francis, Manish Sharma & Alison J. Moskowitz. (2019) Nivolumab Combined With Brentuximab Vedotin for Relapsed/Refractory Primary Mediastinal Large B-Cell Lymphoma: Efficacy and Safety From the Phase II CheckMate 436 Study. Journal of Clinical Oncology 37:33, pages 3081-3089.
Crossref
Crossref
David PfauDaniel A. SmithRose BeckKianoush Ansari GilaniAmit GuptaPaolo CaimiNikhil H. Ramaiya. (2019) Primary Mediastinal Large B-Cell Lymphoma: A Review for Radiologists. American Journal of Roentgenology 213:5, pages W194-W210.
Crossref
Crossref
Luca Ceriani, Lisa Milan, Peter W. M. Johnson, Maurizio Martelli, Stefano Presilla, Luca Giovanella & Emanuele Zucca. (2019) Baseline PET features to predict prognosis in primary mediastinal B cell lymphoma: a comparative analysis of different methods for measuring baseline metabolic tumour volume. European Journal of Nuclear Medicine and Molecular Imaging 46:6, pages 1334-1344.
Crossref
Crossref
Kate Cwynarski, Maria A. V. Marzolini, Sally F. Barrington, George Follows, Timothy Illidge, Simon Stern & Andrew Davies. (2019) The management of primary mediastinal B‐cell lymphoma: a British Society for Haematology Good Practice Paper. British Journal of Haematology 185:3, pages 402-409.
Crossref
Crossref
Charlotte Lees, Colm Keane, Maher K. Gandhi & Jay Gunawardana. (2019) Biology and therapy of primary mediastinal B‐cell lymphoma: current status and future directions. British Journal of Haematology 185:1, pages 25-41.
Crossref
Crossref
Ayman Alhejazi, Ibraheem Motabi, Ahmed Sagheir, Musa Alzahrani, Reyad Dada, Mubarak Al-Mansour, Hani Alhashmi & Magdy Kandil. (2019) Primary mediastinal large B-Cell lymphoma: Saudi Lymphoma Group's clinical practice guidelines for diagnosis, management and follow-up. Saudi Journal of Medicine and Medical Sciences 7:3, pages 231.
Crossref
Crossref
Sarah Tomassetti, Robert Chen & Savita Dandapani. (2019) The role of pembrolizumab in relapsed/refractory primary mediastinal large B-cell lymphoma. Therapeutic Advances in Hematology 10, pages 204062071984159.
Crossref
Crossref
Lisa Giulino-Roth & Kieron Dunleavy. 2019. Non-Hodgkin's Lymphoma in Childhood and Adolescence. Non-Hodgkin's Lymphoma in Childhood and Adolescence
185
193
.
Jeremy S. Abramson & Armando López-Guillermo. 2019. Lexikon der Medizinischen Laboratoriumsdiagnostik. Lexikon der Medizinischen Laboratoriumsdiagnostik
201
212
.
O P Trofimova, I Z Zavodnova, G S Tumyan, Yu I Pryamikova, N V Volkova, O S Zaichenko & A V Nazarenko. (2018) Modern radiation therapy in part of treatment primary mediastinal (thymic) B-large cell lymphoma (results of 131 patients treated at N.N.Blokhin National Medical Research Center of Oncology of the Ministry of Health of the Russian Federation). Journal of Modern Oncology 20:4, pages 5-15.
Crossref
Crossref
Santosha Vardhana, Paul A. Hamlin, Joanna Yang, Andrew Zelenetz, Craig S. Sauter, Matthew J. Matasar, Andy Ni, Joachim Yahalom & Craig H. Moskowitz. (2018) Outcomes of Relapsed and Refractory Primary Mediastinal (Thymic) Large B Cell Lymphoma Treated with Second-Line Therapy and Intent to Transplant. Biology of Blood and Marrow Transplantation 24:10, pages 2133-2138.
Crossref
Crossref
Alessandro Broccoli & Pier Luigi Zinzani. (2018) The unique biology and treatment of primary mediastinal B-cell lymphoma. Best Practice & Research Clinical Haematology 31:3, pages 241-250.
Crossref
Crossref
Lisa Giulino-Roth. (2018) How I treat primary mediastinal B-cell lymphoma. Blood 132:8, pages 782-790.
Crossref
Crossref
Eva González-Barca, Mónica Coronado, Alejandro Martín, Carlos Montalbán, Santiago Montes-Moreno, Carlos Panizo, Guillermo Rodríguez, Juan Manuel Sancho & Andrés López-Hernández. (2018) Spanish Lymphoma Group (GELTAMO) guidelines for the diagnosis, staging, treatment, and follow-up of diffuse large B-cell lymphoma. Oncotarget 9:64, pages 32383-32399.
Crossref
Crossref
Irit Avivi, Ariane Boumendil, Hervé Finel, Arnon Nagler, Aïda Botelho de Sousa, Josep Maria Ribera Santasusana, Elizabeth Vandenberghe, Boris Afanasyev, Dominique Bordessoule, José Maria Moraleda, Eulogio Conde Garcia, David Pohlreich, Gonzalo Gutiérrez Garcia, Kirsty Thomson, Reuven Or, Dietrich Beelen, Eliana Zuffa, Sebastian Giebel, Christian Berthou, Gilles Salles, Angela Melpignano, Silvia Montoto & Peter Dreger. (2018) Autologous stem cell transplantation for primary mediastinal B-cell lymphoma: long-term outcome and role of post-transplant radiotherapy. A report of the European Society for Blood and Marrow Transplantation. Bone Marrow Transplantation 53:8, pages 1001-1009.
Crossref
Crossref
Luca Ceriani, Lisa MilanMaurizio MartelliAndrés J. M. FerreriLuciano CascionePier Luigi ZinzaniAlice Di RoccoAnnarita ConconiAnastasios StathisFranco CavalliMonica BelleiKelly Cozens, Elena PorroLuca Giovanella, Peter W. Johnson & Emanuele Zucca. (2018) Metabolic heterogeneity on baseline 18FDG-PET/CT scan is a predictor of outcome in primary mediastinal B-cell lymphoma. Blood 132:2, pages 179-186.
Crossref
Crossref
Chelsea C. PinnixAndrea K. NgBouthaina S. DabajaSarah A. MilgromJillian R. GuntherC. David FullerGrace L. SmithZeinab Abou YehiaWei QiaoChristine F. WoganMani AkhtariOsama MawlawiL. Jeffrey Medeiros, Hubert H. ChuangWilliam Martin-Doyle, Philippe Armand, Ann S. LaCasce, Yasuhiro Oki, Michelle Fanale, Jason Westin, Sattva Neelapu & Loretta Nastoupil. (2018) Positron emission tomography–computed tomography predictors of progression after DA-R-EPOCH for PMBCL. Blood Advances 2:11, pages 1334-1343.
Crossref
Crossref
Andrea K. Ng, Joachim Yahalom, Jayant S. Goda, Louis S. Constine, Chelsea C. Pinnix, Chris R. Kelsey, Bradford Hoppe, Masahiko Oguchi, Chang-Ok Suh, Andrew Wirth, Shunan Qi, Andrew Davies, Craig H. Moskowitz, Siddhartha Laskar, Yexiong Li, Peter M. Mauch, Lena Specht & Timothy Illidge. (2018) Role of Radiation Therapy in Patients With Relapsed/Refractory Diffuse Large B-Cell Lymphoma: Guidelines from the International Lymphoma Radiation Oncology Group. International Journal of Radiation Oncology*Biology*Physics 100:3, pages 652-669.
Crossref
Crossref
Luca Ceriani, Sally Barrington, Alberto Biggi, Bogdan Malkowski, Ur Metser, Annibale Versari, Maurizio Martelli, Andrew Davies, Peter W. Johnson, Emanuele Zucca & Stéphane Chauvie. (2017) Training improves the interobserver agreement of the expert positron emission tomography review panel in primary mediastinal B-cell lymphoma: interim analysis in the ongoing International Extranodal Lymphoma Study Group-37 study. Hematological Oncology 35:4, pages 548-553.
Crossref
Crossref
Julien Lazarovici, Marie Terroir, Julia Arfi-Rouche, Jean-Marie Michot, Sacha Mussot, Valentina Florea, Maria-Rosa Ghigna, Peggy Dartigues, Cynthia Petrovanu, Alina Danu, Christophe Fermé, Vincent Ribrag & David Ghez. (2017) Poor predictive value of positive interim FDG-PET/CT in primary mediastinal large B-cell lymphoma. European Journal of Nuclear Medicine and Molecular Imaging 44:12, pages 2018-2024.
Crossref
Crossref
Pier Luigi ZinzaniVincent RibragCraig H. MoskowitzJean-Marie MichotJohn KuruvillaArun Balakumaran, Yayan Zhang, Sabine Chlosta, Margaret A. Shipp & Philippe Armand. (2017) Safety and tolerability of pembrolizumab in patients with relapsed/refractory primary mediastinal large B-cell lymphoma. Blood 130:3, pages 267-270.
Crossref
Crossref
Maurizio Martelli, Andrés Ferreri, Alice Di Rocco, Michela Ansuinelli & Peter W.M. Johnson. (2017) Primary mediastinal large B-cell lymphoma. Critical Reviews in Oncology/Hematology 113, pages 318-327.
Crossref
Crossref
Pier Luigi ZinzaniCinzia PellegriniAnnalisa ChiappellaAlice Di RoccoFlavia Salvi, Maria Giuseppina Cabras, Lisa ArgnaniVittorio Stefoni. (2017) Brentuximab vedotin in relapsed primary mediastinal large B-cell lymphoma: results from a phase 2 clinical trial. Blood 129:16, pages 2328-2330.
Crossref
Crossref
Gayane Sergeevna Tumyan, I.Z. Zavodnova, M.Yu. Kichigina & E.G. Medvedovskaya. (2017) Primary Mediastinal (Thymic) Large B-Cell Lymphoma. Clinical oncohematology 10:1, pages 13-24.
Crossref
Crossref
Luca Ceriani, Maurizio Martelli, Maria K. Gospodarowicz, Umberto Ricardi, Andrés J.M. Ferreri, Annalisa Chiappella, Caterina Stelitano, Monica Balzarotti, Maria E. Cabrera, David Cunningham, Attilio Guarini, Pier Luigi Zinzani, Luca Giovanella, Peter W.M. Johnson & Emanuele Zucca. (2017) Positron Emission Tomography/Computed Tomography Assessment After Immunochemotherapy and Irradiation Using the Lugano Classification Criteria in the IELSG-26 Study of Primary Mediastinal B-Cell Lymphoma. International Journal of Radiation Oncology*Biology*Physics 97:1, pages 42-49.
Crossref
Crossref
Andrea K. Ng. 2017. Radiation Therapy in Hematologic Malignancies. Radiation Therapy in Hematologic Malignancies
73
83
.
Pier Luigi Zinzani & Alessandro Broccoli. (2016) Optimizing Outcomes in Primary Mediastinal B-cell Lymphoma. Hematology/Oncology Clinics of North America 30:6, pages 1261-1275.
Crossref
Crossref
Franco CavalliLuca CerianiEmanuele Zucca. (2016) Functional Imaging Using 18-Fluorodeoxyglucose PET in the Management of Primary Mediastinal Large B-Cell Lymphoma: The Contributions of the International Extranodal Lymphoma Study Group. American Society of Clinical Oncology Educational Book:36, pages e368-e375.
Crossref
Crossref
Ya. K. Mangasarova, A. U. Magomedova, E. S. Nesterova, E. M. Volodicheva, V. I. Vorobyev & S. K. Kravchenko. (2016) Therapy for primary mediastinal large B-cell lymphoma in accordance with the R-DA-EPOCH-21 program: The first results. Terapevticheskii arkhiv 88:7, pages 37.
Crossref
Crossref
Karen M. Winkfield, Richard W. Tsang & Mary K. Gospodarowicz. 2016. Clinical Radiation Oncology. Clinical Radiation Oncology
1524
1546.e7
.
T Aoki, K Shimada, R Suzuki, K Izutsu, A Tomita, Y Maeda, J Takizawa, K Mitani, T Igarashi, K Sakai, K Miyazaki, K Mihara, K Ohmachi, N Nakamura, H Takasaki, H Kiyoi, S Nakamura, T Kinoshita & M Ogura. (2015) High-dose chemotherapy followed by autologous stem cell transplantation for relapsed/refractory primary mediastinal large B-cell lymphoma. Blood Cancer Journal 5:12, pages e372-e372.
Crossref
Crossref
Clémentine Sarkozy & Bertrand Coiffier. (2015) Primary refractory diffuse large B cell lymphoma in the rituximab era. Current Opinion in Oncology 27:5, pages 377-383.
Crossref
Crossref
Luca CerianiMaurizio MartelliPier Luigi ZinzaniAndrés J. M. FerreriBarbara BottoCaterina StelitanoManuel GottiMaria Giuseppina CabrasLuigi RigacciLivio GargantiniFrancesco MerliGraziella PinottiDonato ManninaStefano Luminari, Anastasios StathisEleonora RussoFranco CavalliLuca GiovanellaPeter W. M. Johnson & Emanuele Zucca. (2015) Utility of baseline 18FDG-PET/CT functional parameters in defining prognosis of primary mediastinal (thymic) large B-cell lymphoma. Blood 126:8, pages 950-956.
Crossref
Crossref
Stefano Luminari, Luca Ceriani & Ulrich Dührsen. (2015) FDG-PET(CT)-adapted trials in non-Hodgkin lymphoma. Clinical and Translational Imaging 3:4, pages 295-307.
Crossref
Crossref
Amanda F. Cashen. 2015. Clinical Guide to Transplantation in Lymphoma. Clinical Guide to Transplantation in Lymphoma
247
251
.
Peter W. M. Johnson. (2015) IV. Masses in the mediastinum: primary mediastinal lymphoma and intermediate types. Hematological Oncology 33:S1, pages 29-32.
Crossref
Crossref
Anna Armatys, Magdalena Szcze?niak, Grzegorz Helbig, Krzysztof Wo?niczka, Agata Wieczorkiewicz-Kabut, Jacek Paj?k, Ma?gorzata Krawczyk-Kuli?Anna Kopi?ska & S?awomira Kyrcz-Krzemie?. (2015) The outcome of primary mediastinal B-cell lymphoma in a single center experience. Acta Haematologica Polonica 46:1, pages 56-60.
Crossref
Crossref
Anna Dabrowska-Iwanicka & Jan A. Walewski. (2014) Primary Mediastinal Large B-cell Lymphoma. Current Hematologic Malignancy Reports 9:3, pages 273-283.
Crossref
Crossref
Maurizio MartelliLuca CerianiEmanuele ZuccaPier Luigi ZinzaniAndrés J.M. FerreriUmberto VitoloCaterina StelitanoErcole BrusamolinoMaria Giuseppina CabrasLuigi RigacciMonica BalzarottiFlavia SalviSilvia MontotoArmando Lopez-GuillermoErica FinolezziStefano A. PileriAndrew DaviesFranco CavalliLuca GiovanellaPeter W.M. Johnson. (2014)
[
18
F]Fluorodeoxyglucose Positron Emission Tomography Predicts Survival After Chemoimmunotherapy for Primary Mediastinal Large B-Cell Lymphoma: Results of the International Extranodal Lymphoma Study Group IELSG-26 Study
. Journal of Clinical Oncology 32:17, pages 1769-1775.
Crossref
Crossref
Vikranth Visvanathan & John Dempster. (2014) Primary mediastinal B-cell lymphoma presenting as dysphagia: case report and literature review. Research 1.
Crossref
Crossref
Peter Johnson, Jan Delabie, Scott Rodig & Maurizio Martelli. 2014. Rare Lymphomas. Rare Lymphomas
195
206
.
Richard W. Tsang & Mary K. Gospodarowicz. 2012. Clinical Radiation Oncology. Clinical Radiation Oncology
1545
1572
.
M. Rieger, A. Österborg, R. Pettengell, D. White, D. Gill, J. Walewski, E. Kuhnt, M. Loeffler, M. Pfreundschuh & A.D. Ho. (2011) Primary mediastinal B-cell lymphoma treated with CHOP-like chemotherapy with or without rituximab: results of the Mabthera International Trial Group study. Annals of Oncology 22:3, pages 664-670.
Crossref
Crossref
Denise M. Oliansky, Myron Czuczman, Richard I. Fisher, Frank D. Irwin, Hillard M. Lazarus, James Omel, Julie Vose, Steven N. Wolff, Roy B. Jones, Philip L. McCarthyJr.Jr. & Theresa Hahn. (2011) The Role of Cytotoxic Therapy with Hematopoietic Stem Cell Transplantation in the Treatment of Diffuse Large B Cell Lymphoma: Update of the 2001 Evidence-Based Review. Biology of Blood and Marrow Transplantation 17:1, pages 20-47.e30.
Crossref
Crossref
Panagiotis Tsirigotis, Liliane Dray, Igor B. Resnick, Aliza Ackerstein, Benjamin Gesundheit, Sharon Elad, Reuven Or & Michael-Yechiel Shapira. (2009) Post-autologous stem cell transplantation administration of rituximab improves the outcome of patients with aggressive B cell non-Hodgkin’s lymphoma. Annals of Hematology 89:3, pages 263-272.
Crossref
Crossref
. (2008) Current Awareness in Hematological Oncology. Hematological Oncology 26:4, pages 253-260.
Crossref
Crossref